In adults w T2DM and established or high risk of ASCVD HF and or CKD tx plan should include agent s that reduce s CV and kidney dz risk e g SGLT2 and or GLP 1 RA for glycemic mgmt and comprehensive CV risk reduction independent of A1C and in consideration

In adults w/ T2DM and established or high risk of ASCVD, HF, and/or CKD, tx plan should include agent(s) that reduce(s) CV and kidney dz risk (e.g., SGLT2 and/or GLP-1 RA) for glycemic mgmt and comprehensive CV risk reduction, independent of A1C and in consideration of person-specific factors. [A]